Results support possible benefits of Tysabri for MS patients

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Results support possible benefits of Tysabri for MS patients

Post by MSUK »

Image

Biogen Idec and Elan Corporation, plc have announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking Tysabri® (natalizumab) experienced an improvement in both their physical function and psychological well-being.

Findings from the study, which was performed in conjunction with HealthCore Inc., a health-outcomes research company, are the first attempt to assess patient experiences with Tysabri in usual-care settings. The data, presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), shows patients report Tysabri has an impact in improving their overall quality of life.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768
MS-UK - http://www.ms-uk.org/
Top
User avatar
HarryZ
Family Elder
Posts: 2572
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada
Contact:
Contact HarryZ

Re: Results support possible benefits of Tysabri for MS pati

Post by HarryZ »

Healthcore is a large shareholder in Biogen/Idec and less than a year ago, publicly attacked James Mullen, Biogen's CEO, for selling massive amounts of stock for his personal gain...thus reducing the value of the company's shares.

Perhaps these testing results may be an attempt to bolster Tysabri's sales and improve the financial situation at Biogen. Just a thought.

Harry
Top
Post Reply

Return to “Tysabri (Antegren, Natalizumab)”